Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-27]

Agency Forms Undergoing Paperwork Reduction Act Review

The Centers for Disease Control and Prevention (CDC) publishes a

list of information collection requests under review by the Office of

Management and Budget (OMB) in compliance with the Paperwork Reduction

Act (44 U.S.C. Chapter 35). To request a copy of these requests, call

the CDC Reports Clearance Office on (404) 639-7090. Send written

comments to CDC, Desk Officer; Human Resources and Housing Branch, New

Executive Office Building, Room 10235; Washington, DC 20503. Written

comments should be received within 30 days of this notice.

The following requests have been submitted for review since the

last publication date on January 16, 1997.

Proposed Projects

1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--

Revision--The National Home and Hospice Care Survey (NHHCS) was

conducted in 1992, 1993, 1994 and 1996. It is part of the long-term

Care component of the National Health Care Survey. Section 306 of the

Public Health Service Act states that the National Center for Health

Statistics ``shall collect statistics on health resources * * * [and]

utilization of health care, including utilization of * * * services of

hospitals, extended care facilities, home health agencies, and other

institutions.'' NHHCS data are used to examine this most rapidly

expanding sector of the health care industry. Data from the NHHCS are

widely used by the health care industry and policy makers for such

diverse analyses as the need for various medical supplies; minority

access to health care; and planning for the health care needs of the

elderly. The NHHCS also reveals detailed information on utilization

patterns, as needed to make accurate assessments of the need for and

costs associated with such care. Data from earlier NHHCS collections

have been used by the Congressional Budget Office, the Bureau of Health

Professions, the Maryland Health Resources Planning Commission, the

National Association for Home Care, and by several newspapers and

journals. Additional uses are expected to be similar to the uses of the

National Nursing Home Survey. NHHCS data cover: baseline data on the

characteristics of hospices and home health agencies in relation to

their patients and staff, Medicare and Medicaid certification, costs to

patients, sources of payment, patients'' functional status and

diagnoses. Data collection is planned for the period July-October,

1997. Survey design is in process now. Sample selection and preparation

of layout forms will precede the data collection by several months. The

total annual burden is 5,000.

------------------------------------------------------------------------

Average

Number of Number of burden/

Respondents respondents responses/ response (in

respondent hours)

------------------------------------------------------------------------

Agency Questionnaire............ 1,200 1 0.333

Current Patient Sampling List... 1,200 1 .333

Current Patient Questionnaire... 1,200 6 .25

Discharged Patient Sampling List 1,200 1 .50

[[Page 4052]]

Discharged Patient Questionnaire 1,200 6 .25

------------------------------------------------------------------------

2. List of Ingredients Added to Tobacco in the Manufacture of

Smokeless Tobacco Products--(0920-0338)--Extension--Oral use of

smokeless tobacco represents a significant health risk which can cause

cancer and a number of noncancerous oral conditions, and can lead to

nicotine addiction and dependence. Furthermore, smokeless tobacco use

is not a safe substitute for cigarette smoking. The Centers for Disease

Control and Prevention's (CDC) Office on Smoking and Health (OSH) has

been delegated the authority for implementing major components of the

Department of Health and Human Services' (HHS) tobacco and health

program, including collection of tobacco ingredients information. HHS's

overall goal is to reduce death and disability resulting from cigarette

smoking and other forms of tobacco use through programs of information,

education and research.

The Comprehensive Smokeless Tobacco Health Education Act of 1986

(15 U.S.C. 4401 et seq., Pub.L. 99-252) requires each person who

manufactures, packages, or imports smokeless tobacco products to

provide the Secretary of HHS with a list of ingredients added to

tobacco in the manufacture of smokeless tobacco products. HHS is

authorized to undertake research, and to report to the Congress (as

deemed appropriate), on the health effects of the ingredients. The

total annual burden is 286.

------------------------------------------------------------------------

Average

Number of Number of burden/

Respondents respondents responses/ response

respondent (in hours)

------------------------------------------------------------------------

Tobacco manufacturers............ 11 1 26

------------------------------------------------------------------------

3. List of Ingredients Added to Tobacco in the Manufacture of

Cigarette Products--(0920-0210)--Reinstatement--Cigarette smoking is

the leading preventable cause of premature death and disability in our

nation. Each year more than 400,000 premature deaths occur as the

result of cigarette smoking related diseases. The Centers for Disease

Control and Prevention (CDC), Office on Smoking and Health has primary

responsibility for the Department of Health and Human Services' (HHS)

smoking and health program. HHS's overall goal is to reduce death and

disability resulting from cigarette smoking and other forms of tobacco

use through programs of information, education and research.

The Comprehensive Smoking Education Act of 1984 (15 U.S.C. 1336

Pub.L. 98-474) requires each person who manufactures, packages, or

imports cigarettes to provide the Secretary of HHS with a list of

ingredients added to tobacco in the manufacture of cigarettes. This

legislation also authorizes HHS to undertake research, and to report to

the Congress (as deemed appropriate), on the health effects of the

ingredients.

In 1993, OMB reinstated approval for collection of ingredients

information (0920-0210) after the expiration of the previous approval;

this current approval expired on December 31, 1996. The total annual

burden is 2,660.

------------------------------------------------------------------------

Average

No. of No. of burden/

Respondents respondents responses/ response

respondent (in hours)

------------------------------------------------------------------------

Tobacco Manufacturers............ 14 1 190

------------------------------------------------------------------------

4. Surveys of State-Based Diabetes Control Cooperative Agreement

Programs--New--Diabetes Mellitus and related complications are the

seventh leading cause of death in the United States, and accounts for

$105 billion in direct medical costs and lost productivity each year.

Approximately 14 million Americans have been diagnosed with diabetes, a

leading cause of new blindness and end-stage renal failure in the

United States and a major co-morbid factor in lower extremity

amputation, cardiovascular disease and related death, and neonatal

morbidity and mortality.

Through the support of the Centers for Disease Control and

Prevention (CDC) ``State-Based Program to Reduce the Burden of

Diabetes: A Health Systems Approach,'' public health departments in 42

states and four U.S. territorial affiliated jurisdictions have been

charged with providing leadership in reducing the gap between what

should be and what is the current standard of diabetes care.

CDC will collect information from diabetes State Program

Coordinators regarding the four key areas of program implementation.

They are (1) Capacity building and infrastructure development, (2)

surveillance and data collection, (3) health systems change, and (4)

working with local programs.

The survey has three main objectives:

1. Document the progress made by Diabetes Control Programs in the

four main areas of program implementation.

2. Assess the relationship between the level of infrastructure

development, and a program's efforts to carry out surveillance

activities, health systems change activities, and work with local

programs. Information will help improve technical assistance (TA) and

guidance offered to states by CDC.

3. Lay the groundwork for an evaluation instrument that can be used

to collect data from Diabetes Control Programs at the end of the

funding cycle in order to assess whether progress in program

implementation and development is linked to reduced diabetes morbidity

and mortality.

The data will result from self-administered mailed surveys sent to

the Program Coordinator in each state. Most questions will be in the

form of

[[Page 4053]]

checklists although each of the four sections contain a number of open-

ended questions for explanation of unique features of programs. It is

expected that the burden in time to each respondent will be about two

(2) hours per Program Coordinator or Designee, resulting in a total

burden of 92 hours. Results will also be made available to participants

upon request. The total annual burden is 84.

------------------------------------------------------------------------

Average

No. of No. of burden

Respondents respondents responses/ response

respondent (in hours)

------------------------------------------------------------------------

Diabetes Program Coordinators.... 42 1 2

------------------------------------------------------------------------

Dated: January 22, 1997.

Wilma G. Johnson,

Acting Associate Director for Policy Planning and Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 97-2000 Filed 1-27-97; 8:45 am]

BILLING CODE 4163-18-P